David Strauss, Founder and CEO
While working with GlaxoSmithKline (GSK), David Strauss, an entrepreneur and pharmaceutical solutions specialist, saw from close quarters how organizations struggled with manual laboratory functions. He developed an electronic lab notebook (ELN) application that was focused on eliminating paper notebooks from the company’s documentation processes. The application was a great success and it was deployed across GSK’s development division that included over 50 Labs and almost 1000 users. As a key contributor, Strauss grew the application over 15 years to service the development organization within GSK creating over 800,000 experiments. SciCord was founded with a vision to maximize compliance and productivity, with work processes that fit the specific documentation needs of a scientific organization. Drawing on his 30 years of industry experience, Strauss and the team at SciCord brought together the compliance and structured aspects of LIMS with the flexibility of ELN.
SciCord develops, markets, and supports a SaaS (Software as a Service) laboratory documentation solution to provide compliance for drug development, quality assurance, quality control, and manufacture functions. SciCord’s ELN comes with plug-and-play capability and a set of pre-configured solutions to automate laboratory functions. The solutions are compliance-ready and customizable, including a full documentation package. SciCord has in-depth experience in designing and implementing analytical templates and streamlining the development process—requirements definition, coding, validation, and maintenance.
“A single information solution struggles to fulfil the diverse requirements of the scientific community—research, QC, development, and manufacture”. SciCord identified a need in the scientific community for a solution which is at the same time flexible, compliant, structured, and easy to administer. Eliminating the ‘one-size fits all’ ELN strategy and combining flexibility and structure, we hold a sweet spot in the industry” says Strauss, co-founder and CEO, SciCord.
Unlike other providers, we deliver solution that’s flexible enough to handle complicated pharmaceutical documentation
“Our solution is ideal for startups that have an innovative idea and require high quality data to support the idea and eventually sell their product either to the FDA or venture capitalist. Our product with plug-and-play templates supports rapid implementation, increases efficiency, is easy-to-use and provides room to grow as the client’s compliance needs multiply. All customers need is a computer and an internet connection and they are ready to run.”
At the core, SciCord specializes in meeting the analytical requirements of scientific organizations. The team helps clients navigate the complex labyrinth of analytical drug development, understand their data and generate regulatory documents—both seamlessly and quickly. Additionally, the SciCord solution supports early phase manufacturing process control, allowing organizations to keep up with their ever-changing processes and complex batch record systems.
Having started its journey in 2014, SciCord was ready with its advanced documentation solution for lab information management within a year. Pearl Therapeutics was an early adopter, implementing SciCord’s solution to assist development of an inhaled product. Inhaled product development involves analysis of multiple components, and results produce a very large data set. Pearl wanted an LIMS application that can acquire raw information directly from the laboratory bench, automate data processing, and produce tables for regulatory documents. “We were able to provide a comprehensive solution through what we call a template-work process. Unlike other providers, we deliver a solution that’s flexible enough to handle complicated pharmaceutical documentation,” notes Strauss.
Scripting similar success stories, SciCord’s team believes that mobility is the key to success in the coming days. The company also envisions becoming platform-agnostic in the near future so that clients can access their solution from any device. “We also plan to make the data to be fully indexed, enabling our clients to attach anything to our application for faster data processing and search capability,” concludes Strauss.